PROVIDER PROFILE · NPI 1770515405

John GandioncoMD

PRACTICEWELLSPAN MEDICAL GROUPSee all providers at this practice →

Internal MedicineDover, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,108

Unique beneficiaries

—

Total services

1,417

Distinct HCPCS

Medicare payment

$99K

Peer benchmark

Total Medicare services vs. 4,434 Internal Medicine providers in PA — top quintile (cohort median 550).

PRESCRIBING · PART D · 2024

Total Rx claims

10,078

Beneficiaries

—

Total drug cost

$659K

Distinct drugs

152

Brand share

17.3%

Top prescribed drugs

Atorvastatin Calcium677 claims

Amlodipine Besylate407 claims

Metformin Hcl362 claims

Levothyroxine Sodium319 claims

Lisinopril305 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where John Gandionco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
YORK HOSPITAL	214	1,965
Rajesh Nallapati Internal Medicine · Dover, PA	21	64
Douglas Barnes Diagnostic Radiology · York, PA	15	44
John Fitzpatrick Diagnostic Radiology · Milford, CT	14	37
BEILIS, HEIDI	13	23
Rasim Oz Diagnostic Radiology · Annapolis, MD	13	34
Michelle Consolini Cardiology · York, PA	13	26
Erich Kim Diagnostic Radiology · York, PA	11	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history